Cite
HARVARD Citation
Guigay, J. et al. (n.d.). PO-091: TPExtreme randomized trial: Docetaxel-Platinum(P)-Cetuximab(C) versus 5FU-P-C in recurrent/metastatic HNSCC. Radiotherapy and oncology. pp. 46-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Guigay, J. et al. (n.d.). PO-091: TPExtreme randomized trial: Docetaxel-Platinum(P)-Cetuximab(C) versus 5FU-P-C in recurrent/metastatic HNSCC. Radiotherapy and oncology. pp. 46-. [Online].